- Report
- October 2022
- 83 Pages
Global
From €6679EUR$7,500USD£5,788GBP
- Report
- September 2022
- 34 Pages
Global
From €4448EUR$4,995USD£3,855GBP
- Report
- September 2022
- 145 Pages
United States
- Report
- September 2022
- 95 Pages
Global
From €3785EUR$4,250USD£3,280GBP
- Report
- September 2022
- 47 Pages
United States
From €908EUR$1,020USD£787GBP
- Report
- September 2022
- 342 Pages
Global
From €8460EUR$9,500USD£7,332GBP
- Report
- September 2022
- 160 Pages
Global
From €4230EUR$4,750USD£3,666GBP
- Report
- August 2022
- 70 Pages
United Kingdom
From €685EUR$769USD£594GBP
€979EUR$1,099USD£848GBP
- Report
- June 2022
- 220 Pages
Global
From €3072EUR$3,450USD£2,663GBP
- Report
- June 2022
- 140 Pages
United States
€12912EUR$14,500USD£11,191GBP
- Report
- May 2022
- 110 Pages
United States
From €4453EUR$5,000USD£3,859GBP
- Report
- May 2022
- 101 Pages
United States
From €4453EUR$5,000USD£3,859GBP
- Report
- May 2022
- 111 Pages
China
From €4453EUR$5,000USD£3,859GBP
- Report
- May 2022
- 22 Pages
Global
- Report
- April 2022
- 25 Pages
United States
- Book
- March 2022
- 238 Pages
- Report
- February 2022
- 602 Pages
Europe
From €8010EUR$8,995USD£6,942GBP
- Report
- January 2022
- 65 Pages
India
From €617EUR$693USD£535GBP
€882EUR$990USD£764GBP
- Report
- January 2022
- 224 Pages
Global
From €4096EUR$4,600USD£3,550GBP
- Report
- January 2022
- 149 Pages
Global
From €3028EUR$3,400USD£2,624GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more